Companies
Merck & Co.
S&P 500Health Care· USA

MRK

Disruptor

Merck & Co.

ODIS

$120.15

-1.05%

Open $121.03·Prev $121.42

as of 13 Apr

DISRUPTOR

Power Core

Merck's moat is the deepest clinical dataset and broadest label footprint in checkpoint inhibitor oncology, embedded into treatment guidelines across more than 40 tumor types worldwide.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Lateral: Defending the Present While Building the Future

ROC 200

+49.3%

Financials

Loading...

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
MRK — Merck & Co. — Power Mapping Analysis — L17X — L17X